DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q1 2016. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $184,000 | -17.5% | 45,976 | +1.1% | 0.00% | 0.0% |
| Q3 2019 | $223,000 | -17.4% | 45,460 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $270,000 | +7.6% | 44,405 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | -52.7% | 43,207 | +9.6% | 0.00% | -50.0% |
| Q4 2018 | $531,000 | -29.0% | 39,424 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $748,000 | -11.5% | 38,557 | +16.6% | 0.00% | -33.3% |
| Q2 2018 | $845,000 | +29.4% | 33,056 | +1.9% | 0.00% | +50.0% |
| Q1 2018 | $653,000 | +9.0% | 32,427 | +8.7% | 0.00% | 0.0% |
| Q4 2017 | $599,000 | -1.2% | 29,838 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $606,000 | +55.8% | 29,250 | +11.3% | 0.00% | 0.0% |
| Q2 2017 | $389,000 | -92.1% | 26,270 | -91.5% | 0.00% | -90.5% |
| Q1 2017 | $4,954,000 | +49.0% | 310,580 | +17.7% | 0.02% | +40.0% |
| Q4 2016 | $3,325,000 | +436.3% | 263,890 | +1092.5% | 0.02% | +400.0% |
| Q3 2016 | $620,000 | +1.1% | 22,130 | +26.3% | 0.00% | 0.0% |
| Q2 2016 | $613,000 | +33.6% | 17,520 | +4.7% | 0.00% | +50.0% |
| Q1 2016 | $459,000 | – | 16,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |